Skip to main content
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapy
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapy
User login
Username
Password
Reset your password
concept
Lead
score
Noncolorectal Gastrointestinal Cancer
1
1
Specialty
Lead
score
Hematology-Oncology
1
1